These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23235317)

  • 1. Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule.
    Nishimura Y; Mimura W; Mohamed Suffian IF; Amino T; Ishii J; Ogino C; Kondo A
    J Biochem; 2013 Mar; 153(3):251-6. PubMed ID: 23235317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.
    Mohamed Suffian IFB; Wang JT; Hodgins NO; Klippstein R; Garcia-Maya M; Brown P; Nishimura Y; Heidari H; Bals S; Sosabowski JK; Ogino C; Kondo A; Al-Jamal KT
    Biomaterials; 2017 Mar; 120():126-138. PubMed ID: 28056402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
    Shishido T; Mieda H; Hwang SY; Nishimura Y; Tanaka T; Ogino C; Fukuda H; Kondo A
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5726-31. PubMed ID: 20801029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.
    Friedman M; Lindström S; Ekerljung L; Andersson-Svahn H; Carlsson J; Brismar H; Gedda L; Frejd FY; Ståhl S
    Biotechnol Appl Biochem; 2009 Aug; 54(2):121-31. PubMed ID: 19492986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand.
    Wållberg H; Löfdahl PK; Tschapalda K; Uhlén M; Tolmachev V; Nygren PK; Ståhl S
    Protein Expr Purif; 2011 Mar; 76(1):127-35. PubMed ID: 21029777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of an optimized scaffold for affibody molecules.
    Feldwisch J; Tolmachev V; Lendel C; Herne N; Sjöberg A; Larsson B; Rosik D; Lindqvist E; Fant G; Höidén-Guthenberg I; Galli J; Jonasson P; Abrahmsén L
    J Mol Biol; 2010 Apr; 398(2):232-47. PubMed ID: 20226194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and export determine the intracellular distribution of hepatitis B virus core protein subunits.
    Weigand K; Knaust A; Schaller H
    J Gen Virol; 2010 Jan; 91(Pt 1):59-67. PubMed ID: 19741067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity-based entrapment of the HER2 receptor in the endoplasmic reticulum using an affibody molecule.
    Vernet E; Konrad A; Lundberg E; Nygren PA; Gräslund T
    J Immunol Methods; 2008 Sep; 338(1-2):1-6. PubMed ID: 18671978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
    Kwon JA; Rho HM
    Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex carriers of affibody-displaying bio-nanocapsules and composition-varied liposomes for HER2-expressing breast cancer cell-specific protein delivery.
    Nishimura Y; Ishii J; Okazaki F; Ogino C; Kondo A
    J Drug Target; 2012 Dec; 20(10):897-905. PubMed ID: 23020553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
    Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
    Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu.
    Magnusson MK; Henning P; Myhre S; Wikman M; Uil TG; Friedman M; Andersson KM; Hong SS; Hoeben RC; Habib NA; Ståhl S; Boulanger P; Lindholm L
    Cancer Gene Ther; 2007 May; 14(5):468-79. PubMed ID: 17273181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of affinity on binding of HER2-targeting Affibody molecules: model experiments in breast cancer spheroids.
    Qvarnström OF; Simonsson M; Carlsson J; Tran TA
    Int J Oncol; 2011 Aug; 39(2):353-9. PubMed ID: 21584491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles.
    Bin Mohamed Suffian IF; Nishimura Y; Morita K; Nakamura-Tsuruta S; Al-Jamal KT; Ishii J; Ogino C; Kondo A
    J Nanobiotechnology; 2015 Feb; 13():15. PubMed ID: 25890025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Targeted detecting HER2 expression with recombinant anti HER2 ScFv-GFP fusion antibody].
    Gao G; Chen C; Yang Y; Yang H; Wang J; Zheng Y; Huang Q; Hu X
    Sheng Wu Gong Cheng Xue Bao; 2012 Aug; 28(8):1002-14. PubMed ID: 23185900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane.
    Hourioux C; Ait-Goughoulte M; Patient R; Fouquenet D; Arcanger-Doudet F; Brand D; Martin A; Roingeard P
    Cell Microbiol; 2007 Apr; 9(4):1014-27. PubMed ID: 17257269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
    Tolmachev V; Orlova A; Pehrson R; Galli J; Baastrup B; Andersson K; Sandström M; Rosik D; Carlsson J; Lundqvist H; Wennborg A; Nilsson FY
    Cancer Res; 2007 Mar; 67(6):2773-82. PubMed ID: 17363599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Serum Albumin and HER2-Binding Affibody Fusion Proteins for Targeted Delivery of Fatty Acid-Modified Molecules and Therapy.
    Dong D; Xia G; Li Z; Li Z
    Mol Pharm; 2016 Oct; 13(10):3370-3380. PubMed ID: 27546214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
    Orlova A; Wållberg H; Stone-Elander S; Tolmachev V
    J Nucl Med; 2009 Mar; 50(3):417-25. PubMed ID: 19223403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and activity identification of APOBEC3A-HBc fusion protein].
    DU J; Cheng S; Bai H; Ji Q; Guo Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1521-1528. PubMed ID: 29268857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.